Charles Ornstein & Katie Thomas

It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs.

Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics.

Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected.